4//SEC Filing
Claiborne Cary J 4
Accession 0001213900-23-043111
CIK 0001513525other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 4:36 PM ET
Size
7.1 KB
Accession
0001213900-23-043111
Insider Transaction Report
Form 4
Claiborne Cary J
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-05-23+300,000→ 300,000 totalExercise: $0.30From: 2023-05-23Exp: 2033-05-23→ Common Stock (300,000 underlying) - Award
Common Stock
2023-05-23+420,000→ 1,520,000 total
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023.
Documents
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001370930
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 4:36 PM ET
- Size
- 7.1 KB